[1]
Anil Kumar, Y. and Chitra, V. 2022. Prospects of Combinatorial Approach Involving ICD Induction and Adenosine A2A Receptor Pathway Inhibition to Improve Cancer Immunotherapy. Toxicology International. 29, 2 (Jul. 2022), 181–193. DOI:https://doi.org/10.18311/ti/2022/v29i2/28974.